V CompBrief BY VELARION

Independent Director · CRESCENT BIOPHARMA, INC. (CBIO)

Chair, Nominating/Governance Committee

Peter Harwin director compensation at Crescent (FY2025): $152K

Fiscal year 2025 director compensation for Peter Harwin at CRESCENT BIOPHARMA, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 21, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Peter Harwin’s full pay file as a PDF — free

More than this page: up to 10 years of Peter’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Peter Harwin and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

CRESCENT BIOPHARMA Director Compensation Table · the one fiscal year held
In US dollars, as CRESCENT BIOPHARMA reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$44,652$0$106,923$0$151,575

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CRESCENT BIOPHARMA, INC. DEF 14A filed April 21, 2026, accession 0001628280-26-026282, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CRESCENT BIOPHARMA, INC. filed document, accession 0001628280-26-026282. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2026.

Get the CRESCENT BIOPHARMA Board Governance Report

$151,575 Peter Harwin, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 21, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

CRESCENT BIOPHARMA pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Nominating/Governance (Chair)

The rest of the CRESCENT BIOPHARMA board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alexandra BalcomIndependent Director$140,466
David LubnerIndependent Director$294,991
Jonathan Violin, Ph.DDirector$474,301
Joshua BrummDirector—
Susan Moran, M.D., MSCEIndependent Director$136,964

The full CRESCENT BIOPHARMA compensation record

free company brief
CRESCENT BIOPHARMA, INC. (CBIO) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within CRESCENT BIOPHARMA's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the CRESCENT BIOPHARMA proxy · each links to its own free brief

Order CBIO

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report